Department of Medical Ethics and Health Policy, Perelman School of Medicine, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.
The Leonard Davis Institute of Health Economics (LDI), University of Pennsylvania, Philadelphia, PA, USA.
Med Decis Making. 2021 Jan;41(1):9-20. doi: 10.1177/0272989X20973160. Epub 2020 Nov 20.
Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff to encourage healthy behaviors are becoming increasingly prevalent and important in health innovation and improvement efforts. Although considerations of cost are key to their wider adoption, cost information is lacking because the resources required cannot be costed using standard administrative billing data. Pragmatic clinical trials that test behavioral interventions are potentially the best and often only source of cost information but rarely incorporate costing studies. This article provides a guide for researchers to help them collect and analyze, during the trial and with little additional effort, the information needed to inform potential adopters of the costs of adopting a behavioral intervention. A key challenge in using trial data is the separation of implementation costs, the costs an adopter would incur, from research costs. Based on experience with 3 randomized clinical trials of behavioral interventions, this article explains how to frame the costing problem, including how to think about costs associated with the control group, and describes methods for collecting data on individual costs: specifications for costing a technology platform that supports the specialized functions required, how to set up a time log to collect data on the time staff spend on implementation, and issues in getting data on device, overhead, and financial incentive costs.
涉及电子设备、经济激励、游戏化和专门培训的员工以鼓励健康行为的行为干预措施在健康创新和改善工作中变得越来越普遍和重要。尽管成本考虑是广泛采用这些措施的关键,但由于无法使用标准行政计费数据对所需资源进行计价,因此缺乏成本信息。检验行为干预措施的实用临床试验可能是成本信息的最佳来源,而且通常也是唯一来源,但很少纳入成本研究。本文为研究人员提供了一个指南,帮助他们在试验期间并只需付出很少的额外努力收集和分析所需信息,为潜在采用者提供有关采用行为干预措施的成本信息。在使用试验数据时的一个关键挑战是将实施成本(采用者将承担的成本)与研究成本分开。基于对 3 项行为干预随机临床试验的经验,本文解释了如何构建成本核算问题,包括如何考虑与对照组相关的成本,以及描述了收集个人成本数据的方法:支持所需专门功能的技术平台的成本核算规范,如何设置时间记录以收集有关员工实施工作时间的数据,以及获取设备、间接费用和经济激励成本数据的问题。